Laporan Laba Rugi MPCI - TTM - Memphis Pharmaceuticals & Chemical Industries

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Memphis Pharmaceuticals & Chemical Industries menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	510	506	506	518	510	507	529	551	573	597	585	664	696	791	888	872	1,089	1,230	1,305
Change (%)		-0.85	-0.09	2.46	-1.50	-0.56	4.25	4.20	3.94	4.14	-1.92	13.43	4.87	13.62	12.26	-1.81	24.89	12.96	6.06
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	407	387	394	353	342	366	386	402	412	418	402	451	477	525	583	573	656	710	729
Change (%)		-4.75	1.64	-10.27	-3.17	7.10	5.31	4.20	2.56	1.40	-3.76	12.09	5.90	10.01	11.06	-1.70	14.45	8.23	2.59
% of Revenue	79.64	76.50	77.83	68.16	67.00	72.17	72.90	72.90	71.93	70.05	68.73	67.92	68.59	66.41	65.69	65.77	60.27	57.74	55.85

Gross Operating Profit	104	119	112	165	168	141	143	149	161	179	183	213	219	266	305	298	433	520	576
Change (%)		14.42	-5.72	47.14	2.08	-16.13	1.51	4.20	7.64	11.14	2.38	16.39	2.69	21.51	14.64	-2.01	44.94	20.14	10.81
% of Revenue	20.36	23.50	22.17	31.84	33.00	27.83	27.10	27.10	28.07	29.95	31.27	32.08	31.41	33.59	34.31	34.23	39.73	42.26	44.15

SG&A	25	30	28	76	86	69	73	72	81	77	75	77	69	78	84	88	92	97	100
Change (%)		19.76	-8.54	174.60	13.50	-19.54	4.84	-1.28	13.38	-5.72	-2.11	3.03	-11.04	13.70	7.74	4.16	4.97	4.75	3.48
% of Revenue	4.95	5.98	5.47	14.66	16.90	13.67	13.75	13.03	14.21	12.86	12.84	11.66	9.89	9.90	9.50	10.08	8.47	7.86	7.66

R&D
Change (%)
% of Revenue

OpEx	490	479	472	484	482	484	501	482	493	504	496	568	588	635	695	686	781	854	874
Change (%)		-2.19	-1.57	2.64	-0.43	0.45	3.55	-3.79	2.34	2.14	-1.54	14.44	3.54	8.04	9.37	-1.21	13.75	9.39	2.33
% of Revenue	95.96	94.66	93.25	93.41	94.42	95.38	94.74	87.48	86.13	84.48	84.81	85.55	84.47	80.32	78.25	78.73	71.70	69.44	67.00

Operating Income	21	27	34	34	28	23	28	69	79	93	89	96	108	156	193	185	308	376	431
Change (%)		31.02	26.21	0.02	-16.62	-17.64	18.79	147.92	15.13	16.53	-4.01	7.85	12.72	44.00	24.07	-3.96	66.13	22.00	14.53
% of Revenue	4.04	5.34	6.75	6.59	5.58	4.62	5.26	12.52	13.87	15.52	15.19	14.45	15.53	19.68	21.75	21.27	28.30	30.56	33.00

Interest Expense																-14	-14	-14	-14
Change (%)																	-0.00	-0.00	-0.00
% of Revenue																-1.64	-1.31	-1.16	-1.09

Net Income	24	33	38	42	39	33	37	74	82	92	88	90	103	146	222	191	308	377	401
Change (%)		35.52	14.22	11.30	-7.74	-15.54	14.91	97.94	10.62	12.33	-4.25	2.59	13.38	42.16	52.12	-13.66	60.64	22.47	6.42
% of Revenue	4.75	6.50	7.43	8.07	7.56	6.42	7.07	13.44	14.30	15.43	15.06	13.62	14.73	18.43	24.97	21.96	28.24	30.62	30.73

Source: Capital IQ

Memphis Pharmaceuticals & Chemical Industries - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)